Stock-Based Compensation (Tables)
|
12 Months Ended |
Jul. 31, 2016 |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
Summary of Stock-based Awards Outstanding by Award Type |
As of July 31, 2016, the following stock-based awards, by award type, were outstanding: | | | | | July 31, 2016 | Stock options | 2,256,679 |
| Performance shares | 173,852 |
| RSUs and restricted stock | 34,858 |
| Share units | 8,503 |
| Total | 2,473,892 |
|
|
Stock-based compensation for awards detailing where recorded in Consolidated Statement of Operations |
Stock-based compensation for awards issued is reflected in the following line items in our Consolidated Statements of Operations: | | | | | | | | | | | | | | Fiscal Years Ended July 31, | | | 2016 | | 2015 | | 2014 | Cost of sales | | $ | 296,000 |
| | 245,000 |
| | 252,000 |
| Selling, general and administrative expenses | | 3,407,000 |
| | 3,507,000 |
| | 3,403,000 |
| Research and development expenses | | 414,000 |
| | 611,000 |
| | 608,000 |
| Stock-based compensation expense before income tax benefit | | 4,117,000 |
| | 4,363,000 |
| | 4,263,000 |
| Estimated income tax benefit | | (1,434,000 | ) | | (1,523,000 | ) | | (1,550,000 | ) | Net stock-based compensation expense | | $ | 2,683,000 |
| | 2,840,000 |
| | 2,713,000 |
|
|
Summary of net stock-based compensation expense by award type |
Stock-based compensation expense, by award type, is summarized as follows: | | | | | | | | | | | | | | Fiscal Years Ended July 31, | | | 2016 | | 2015 | | 2014 | Stock options | | $ | 2,353,000 |
| | 2,842,000 |
| | 2,752,000 |
| Performance shares | | 1,374,000 |
| | 890,000 |
| | 976,000 |
| ESPP | | 163,000 |
| | 206,000 |
| | 184,000 |
| RSUs and restricted stock | | 227,000 |
| | 397,000 |
| | 293,000 |
| Share units | | — |
| | 28,000 |
| | 41,000 |
| Equity-classified stock-based compensation expense | | 4,117,000 |
| | 4,363,000 |
| | 4,246,000 |
| Liability-classified stock-based compensation expense (SARs) | | — |
| | — |
| | 17,000 |
| Stock-based compensation expense before income tax benefit | | 4,117,000 |
| | 4,363,000 |
| | 4,263,000 |
| Estimated income tax benefit | | (1,434,000 | ) | | (1,523,000 | ) | | (1,550,000 | ) | Net stock-based compensation expense | | $ | 2,683,000 |
| | 2,840,000 |
| | 2,713,000 |
|
|
Components of actual Income tax benefit recognized for tax deductions relating to settlement of stock-based awards |
The following table reconciles the actual income tax benefit recognized for tax deductions relating to the settlement of stock-based awards to the excess income tax benefit reported as a cash flow from financing activities in our Consolidated Statements of Cash Flows: | | | | | | | | | | | | | | | Fiscal Years Ended July 31, | | | 2016 | | 2015 | | 2014 | Actual income tax benefit recorded for the tax deductions relating to the settlement of stock-based awards | | $ | 196,000 |
| | 1,108,000 |
| | $ | 2,339,000 |
| Less: Tax benefit initially recognized on settled stock-based awards vesting subsequent to the adoption of accounting standards that require us to expense stock-based awards | | 168,000 |
| | 960,000 |
| | 1,540,000 |
| Excess income tax benefit recorded as an increase to additional paid-in capital | | 28,000 |
| | 148,000 |
| | 799,000 |
| Less: Tax benefit initially disclosed but not previously recognized on settled equity-classified stock-based awards vesting prior to the adoption of accounting standards that require us to expense stock-based awards | | — |
| | — |
| | 61,000 |
| Excess income tax benefit from settled equity-classified stock-based awards reported as a cash flow from financing activities in our Consolidated Statements of Cash Flows | | $ | 28,000 |
| | 148,000 |
| | 738,000 |
|
|
Summary of the Plan's activity relating to stock options (including SARs) |
The following table summarizes the Plan's activity (including SARs): | | | | | | | | | | | | | | | | | Awards (in Shares) | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value | Outstanding at July 31, 2013 | | 3,047,910 |
| | $ | 29.94 |
| | | | | Granted | | 458,110 |
| | 29.14 |
| | | | | Expired/canceled | | (492,060 | ) | | 42.90 |
| | | | | Exercised | | (881,064 | ) | | 26.55 |
| | | | | Outstanding at July 31, 2014 | | 2,132,896 |
| | 28.17 |
| | | | | Granted | | 416,525 |
| | 33.78 |
| | | | | Expired/canceled | | (46,400 | ) | | 30.20 |
| | | | | Exercised | | (383,338 | ) | | 27.61 |
| | | | | Outstanding at July 31, 2015 | | 2,119,683 |
| | 29.33 |
| | | | | Granted | | 552,806 |
| | 27.15 |
| | | | | Expired/canceled | | (396,610 | ) | | 28.99 |
| | | | | Exercised | | (19,200 | ) | | 27.24 |
| | | | | Outstanding at July 31, 2016 | | 2,256,679 |
| | $ | 28.87 |
| | 6.67 | | $ | 1,000 |
| | | | | | | | | | Exercisable at July 31, 2016 | | 1,154,882 |
| | $ | 28.60 |
| | 5.42 | | $ | — |
| | | | | | | | | | Vested and expected to vest at July 31, 2016 | | 2,174,225 |
| | $ | 28.86 |
| | 6.62 | | $ | 1,000 |
|
|
Certain weighted average assumptions used to estimate initial fair value of stock options |
The estimated per-share weighted average grant-date fair value of stock options granted during fiscal 2016, 2015 and 2014 was $5.50, $6.12 and $5.35, respectively, which was determined using the Black-Scholes option pricing model, and included the following weighted average assumptions: | | | | | | | | | | | | | Fiscal Years Ended July 31, | | | 2016 | | 2015 | | 2014 | Expected dividend yield | | 4.46 | % | | 3.55 | % | | 3.94 | % | Expected volatility | | 34.44 | % | | 28.19 | % | | 30.36 | % | Risk-free interest rate | | 1.52 | % | | 1.61 | % | | 1.47 | % | Expected life (years) | | 5.15 |
| | 5.44 |
| | 5.32 |
|
|
Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units |
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock and share units: | | | | | | | | | | | | | | | Awards (in Shares) | | Weighted Average Grant Date Fair Value | | Aggregate Intrinsic Value | Outstanding at July 31, 2013 | | 102,334 |
| | $ | 25.80 |
| | | Granted | | 95,326 |
| | 26.48 |
| | | Converted to common stock | | (7,857 | ) | | 26.18 |
| | | Forfeited | | (9,706 | ) | | 24.83 |
| | | Outstanding at July 31, 2014 | | 180,097 |
| | 26.20 |
| | | Granted | | 66,294 |
| | 33.96 |
| | | Converted to common stock | | (18,422 | ) | | 27.79 |
| | | Forfeited | | (3,804 | ) | | 32.47 |
| | | Outstanding at July 31, 2015 | | 224,165 |
| | 28.26 |
| | | Granted | | 71,605 |
| | 27.45 |
| | | Converted to common stock | | (16,439 | ) | | 26.35 |
| | | Forfeited | | (62,118 | ) | | 27.62 |
| | | Outstanding at July 31, 2016 | | 217,213 |
| | $ | 28.32 |
| | $ | 2,839,000 |
| | | | | | | | Vested at July 31, 2016 | | 35,855 |
| | $ | 27.24 |
| | $ | 469,000 |
| | | | | | | | Vested and expected to vest at July 31, 2016 | | 209,521 |
| | $ | 28.26 |
| | $ | 2,738,000 |
|
|